Antibody Drug Conjugates (ADCs) in NSCLC

Episode
105
Soundcloud
Share

What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore.

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Rebecca Heist
Rebecca Heist
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Ben Levy
Ben Levy

MD

MD Associate Professor
Johns Hopkins School of Medicine
Johns Hopkins Sidney Kimmel Cancer Center

Other Podcast

ASCO 2024 Highlights Part 2
Episode
222
ASCO 2024 Highlights Part 1
Episode
221
An Update on Lung Cancer Screening
Episode
220
LCC on World No Tobacco Day
Episode
219